SUE HIGH: Open Payments
NPI 1649406810 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 36 payments from 14 companies in 2025. Trend: 2023 $999 · 2024 $931 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Alexion Pharmaceuticals, Inc. | 5 | $107 |
| Fresenius USA Marketing, Inc. | 4 | $82 |
| Calliditas Therapeutics US Inc. | 2 | $62 |
| Travere Therapeutics, Inc. | 5 | $53 |
| Amgen Inc. | 3 | $51 |
| Vifor Pharma, Inc. | 2 | $42 |
| Ardelyx, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
Products named: FARXIGA, ULTOMIRIS, VELPHORO, TARPEYO, JARDIANCE, Veltassa, IBSRELA, ACTHAR.
Industry payments across NC — which companies pay providers there.
